Atlas Trials

Does Gabapentin Reduce Quadriceps Muscle Weakness After Anterior Cruciate Ligament Reconstruction?

Clinical trial NCT03496389 · UNKNOWN

Trial details

NCT number
NCT03496389
Sponsor
Hospital Authority, Hong Kong
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Muscle WeaknessAnterior Cruciate Ligament Rupture
Start date
2018-07-01
Primary completion
2019-07-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.